Table of Content



1. Executive Summary

2. Global Inactivated Vaccine Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Inactivated Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Inactivated Vaccine Market by Type
3.3.1: Viral
3.3.2: Bacterial
3.3.3: others
3.4: Global Inactivated Vaccine Market by End Use
3.4.1: Hospitals
3.4.2: Homecare
3.4.3: Specialty Clinics
3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Inactivated Vaccine Market by Region
4.2: North American Inactivated Vaccine Market
4.2.1: North American Market by Type: Viral, Bacterial, and others
4.2.2: North American Market by End Use: Hospitals, Homecare, Specialty Clinics, and Others
4.3: European Inactivated Vaccine Market
4.3.1: European Market by Type: Viral, Bacterial, and others
4.3.2: European Market by End Use: Hospitals, Homecare, Specialty Clinics, and Others
4.4: APAC Inactivated Vaccine Market
4.4.1: APAC Market by Type: Viral, Bacterial, and others
4.4.2: APAC Market by End Use: Hospitals, Homecare, Specialty Clinics, and Others
4.5: ROW Inactivated Vaccine Market
4.5.1: ROW Market by Type: Viral, Bacterial, and others
4.5.2: ROW Market by End Use: Hospitals, Homecare, Specialty Clinics, and Others

5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis

6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Inactivated Vaccine Market by Type
6.1.2: Growth Opportunities for the Global Inactivated Vaccine Market by End Use
6.1.3: Growth Opportunities for the Global Inactivated Vaccine Market by Region
6.2: Emerging Trends in the Global Inactivated Vaccine Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Inactivated Vaccine Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Inactivated Vaccine Market
6.3.4: Certification and Licensing

7. Company Profiles of Leading Players
7.1: Pfizer
7.2: Sanofi
7.3: GlaxoSmithKline
7.4: Merck
7.5: AstraZeneca
7.6: Johnson & Johnson
7.7: CSL Behring